David Keene is the founder of Mirai Bio. Mirai Bio has raised $120M in total funding. Latest round: Series A. Backed by Flagship Pioneering.
David Keene is the Vice President, Finance at Mirai Bio, a company where he leverages his accounting expertise and experience in biotech and MedTech to manage strategic financial planning, budgeting, and reporting. Prior to Mirai Bio, he served as Vice President and Corporate Controller at ElevateBio Technologies, establishing and managing accounting operations. Earlier in his career, he held leadership roles at Organogenesis Holding Inc., RainDance Technologies, and Cyberkinetics Neurotechnology Systems, and began his career at Ernst & Young LLP.
Full founder directory · Investor directory · Company funding database · Fundraising library